Cancer
Malignant Thyroid Gland Neoplasm
CI-CAN-00003251Explore in graph →
Top-level176 active trials10 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003251Explore in graph →
Clinical trials
790 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (65)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06923826 | Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)(TROP2) | recruiting | Phase 2 | 32 | National University Hospital, SingaporeOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT07072143 | An International Study on Pediatric Patients With Rare Tumors.(PARTNER) | recruiting | — | 6,250 | Azienda Ospedaliera di PadovaOTHER | 1 | Jul 18, 2025 |
| clinicaltrials |
| NCT07062211 | Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level | active not recruiting | — | 39 | Superior UniversityOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT07056218 | Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk) | not yet recruiting | — | 50 | Sohag UniversityOTHER | 0 | Jul 9, 2025 | clinicaltrials |
| NCT07048964 | A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations | not yet recruiting | — | 40 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Jul 3, 2025 | clinicaltrials |
| NCT07042984 | RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer(RET-US) | not yet recruiting | — | 800 | Fujian Medical UniversityOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors(SPARTA) | recruiting | Phase 2 | 497 | Apollomics Inc.INDUSTRY | 11 | Jun 27, 2025 | clinicaltrials |
| NCT06849284 | To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers. | recruiting | — | 100 | Royal Cornwall Hospitals TrustOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06254859 | Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery | recruiting | — | 100 | Fujian Medical UniversityOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06971965 | Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.(MAeSTro-TSH) | not yet recruiting | N/A | 578 | National Cancer Center, KoreaOTHER_GOV | 0 | May 14, 2025 | clinicaltrials |
| NCT06261190 | Active Surveillance for Low-risk Papillary Thyroid Carcinoma(MAeSTro-EXP) | enrolling by invitation | — | 499 | National Cancer Center, KoreaOTHER_GOV | 1 | May 11, 2025 | clinicaltrials |
| NCT06730893 | Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer(MAeSTro-SDM) | not yet recruiting | N/A | 310 | National Cancer Center, KoreaOTHER_GOV | 0 | Apr 30, 2025 | clinicaltrials |
| NCT06937112 | 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis | recruiting | — | 20 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT05541380 | A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID) | active not recruiting | — | 300 | National Health Research Institutes, TaiwanOTHER | 1 | Apr 20, 2025 | clinicaltrials |
| NCT06929650 | The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer | recruiting | N/A | 40 | University Health Network, TorontoOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT04706962 | TH1902 in Patients With Advanced Solid Tumors | active not recruiting | Phase 1 | 70 | TheratechnologiesINDUSTRY | 2 | Apr 15, 2025 | clinicaltrials |
| NCT06918223 | Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery(TISCAV) | recruiting | N/A | 60 | Thomas Jefferson UniversityOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT05275374 | XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation(ENHANCE) | not yet recruiting | Phase 1 / Phase 2 | 221 | Xynomic Pharmaceuticals, Inc.INDUSTRY | 0 | Apr 10, 2025 | clinicaltrials |
| NCT06840106 | Nasal Steam Therapy for Post-extubation Respiratory Events(PURE) | recruiting | N/A | 66 | Ilsan Cha hospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT04420754 | Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer | active not recruiting | Phase 1 | 70 | AffyImmune Therapeutics, Inc.INDUSTRY | 1 | Mar 30, 2025 | clinicaltrials |
| NCT04802876 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors(ACROPOLI) | active not recruiting | Phase 2 | 184 | SOLTI Breast Cancer Research GroupOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06878534 | Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy(TRAMT) | recruiting | — | 80 | IRCCS SYNLAB SDNOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT06863805 | Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas | recruiting | — | 10 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06851260 | The Importance of Thymus Anatomy to the Radical Resection of Thyroid Cancer Surgery and the Protection of Parathyroid Function | not yet recruiting | N/A | 5 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Feb 28, 2025 | clinicaltrials |
| NCT06852144 | PET-TC in Thyroid Evaluation(PEPATI-MN-2024) | enrolling by invitation | — | 418 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06848920 | Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma | not yet recruiting | Phase 2 | 20 | Zhejiang UniversityOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06835426 | High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins | recruiting | N/A | 150 | Algemeen Ziekenhuis Maria MiddelaresOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06733740 | Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma | recruiting | — | 3,000 | Chinese PLA General HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06733766 | Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer | recruiting | — | 300 | Chinese PLA General HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06804863 | Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer | not yet recruiting | N/A | 600 | West China HospitalOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT03382158 | International PPB/DICER1 Registry | recruiting | — | 3,400 | Children's Hospitals and Clinics of MinnesotaOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06800482 | A Study of Online Follow-up in Patients With Papillary Thyroid Cancer | recruiting | N/A | 388 | West China HospitalOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06800768 | The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery | recruiting | — | 40 | Ruijin HospitalOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06791005 | A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer. | recruiting | Phase 3 | 400 | Second Affiliated Hospital of Xi'an Jiaotong UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06787807 | Proteomic Analysis of Patients Undergoing Bariatric Surgery | not yet recruiting | N/A | 103 | Universidade Federal de PernambucoOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06787911 | Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer | recruiting | Phase 2 | 14 | Yu WangOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06779747 | Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology | recruiting | — | 5,850 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT05377736 | Thyroid Nodule Gene Sequencing in a Danish Population | active not recruiting | N/A | 30 | Aarhus University HospitalOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06725576 | Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma | recruiting | — | 201 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT05668962 | Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC | recruiting | Phase 2 | 30 | Massachusetts General HospitalOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06730529 | The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases | recruiting | — | 40 | Ruijin HospitalOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06730971 | This Study is Mainly About Finding Incidence Among Other Factors of Thyroid Cancer in Patient with Benign Disease As MNG to Early Discover of the Malignancy to Save the Patient from Aggressive Procedure | not yet recruiting | — | 300 | Asmaa Mohamed EmamOTHER | 0 | Dec 12, 2024 | clinicaltrials |
| NCT06725628 | Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma | not yet recruiting | — | 2,000 | Tianhan ZhouOTHER_GOV | 0 | Dec 10, 2024 | clinicaltrials |
| NCT06236373 | The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia(Survivorship) | recruiting | — | 45 | University of Modena and Reggio EmiliaOTHER | 1 | Dec 9, 2024 | clinicaltrials |
| NCT06482086 | Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer | recruiting | Phase 2 | 75 | West China HospitalOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT06713057 | Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer | not yet recruiting | Phase 2 | 20 | West China HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT05424692 | Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer | recruiting | N/A | 200 | Peking Union Medical College HospitalOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06583395 | Quest to Analyze One Thousand Humans Meditating(QUANTUM) | enrolling by invitation | — | 3,000 | Tobias Moeller-BertramINDUSTRY | 1 | Nov 1, 2024 | clinicaltrials |
| NCT06149637 | Lateral Cervical Node Dissection in Differentiated Thyroid Cancer. | recruiting | N/A | 62 | Centro de Excelencia en Enfermedades de Cabeza y CuelloOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT05620134 | Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer | active not recruiting | Phase 1 / Phase 2 | 263 | Salubris Biotherapeutics IncINDUSTRY | 2 | Oct 15, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Jul 25, 2025source: clinicaltrials